Patrick Decker - 14 Nov 2023 Form 4 Insider Report for Xylem Inc. (XYL)

Reporting relationship: President & CEO, Director
Issuer ticker: XYL
Reported as of: 14 Nov 2023
Net transaction value: -$6,465,404
SEC form: 4
Accepted by SEC: 16 Nov 2023, 17:22:53 UTC
Prior SEC filing: 06 Jul 2023
Next SEC filing: 02 Jan 2024
Source filing: View source filing
Reporting owner signature: /s/ Callie Plant, by power of attorney for Patrick K. Decker

Key filing fact

Patrick Decker filed Form 4 for Xylem Inc. (XYL) on 16 Nov 2023.

Key facts

This page summarizes Patrick Decker's Form 4 filing for Xylem Inc. (XYL).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 16 Nov 2023, 17:22.

Change

Previous filing in this sequence was filed on 06 Jul 2023.
Current net transaction value: -$6,465,404.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XYL transaction

Common Stock

Options Exercise

Transaction value: $3,583,342
Shares: +99,648
Change %: +35%
Price: $35.96
Shares after: 387,212
Date: 14 Nov 2023
Ownership: Direct

XYL transaction

Common Stock

Sale

Transaction value: $5,074,319
Shares: -50,458
Change %: -13%
Price: $100.57
Shares after: 336,754
Date: 14 Nov 2023
Ownership: Direct
Footnotes: F1, F2

XYL transaction

Common Stock

Sale

Transaction value: $4,974,427
Shares: -49,190
Change %: -15%
Price: $101.13
Shares after: 287,564
Date: 14 Nov 2023
Ownership: Direct
Footnotes: F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

XYL transaction Derivative

Non-Qualified Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -99,648
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 14 Nov 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 99,648
Exercise price: $35.96
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 10, 2023.

Footnote F2

This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a range of prices from $100.04 to $101.035. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

Footnote F3

This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a range of prices from $101.04 to $101.30. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

Footnote F4

The February 24, 2015 option grant vested one-third on February 24, 2016, February 24, 2017 and February 24, 2018.